Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.

He L, Gao L, Shay C, Lang L, Lv F, Teng Y
J Exp Clin Cancer Res. 2019 Feb 18;38(1):84. doi: 10.1186/s13046-019-1080-8. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.